• Ionis Pharmaceuticals EPS for the quarter ending December 31, 2024 was $-0.66, a 1000% increase year-over-year.
• Ionis Pharmaceuticals 2024 annual EPS was $-3.04, a 18.75% increase from 2023.
• Ionis Pharmaceuticals 2023 annual EPS was $-2.56, a 34.74% increase from 2022.
• Ionis Pharmaceuticals 2022 annual EPS was $-1.9, a 850% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.